Trump Administration Drafts Executive Order to Probe Vaccine-Autism Link

The Trump administration is drafting an executive order to investigate potential links between childhood vaccines and autism. The move signals a direct challenge to the long-standing scientific consensus that no such connection exists.

According to reports from Bloomberg and other outlets, the White House is actively preparing the order, which would likely direct federal health agencies to review the current childhood vaccination schedule and initiate new research into vaccine safety. HHS Secretary Robert F. Kennedy Jr. has confirmed that President Trump wants a federal probe into the vaccine-autism link, positioning the investigation as a priority for the administration.

A Shift in Public Health Policy

This initiative is part of a broader administration effort to revisit U.S. public health priorities and challenge what it describes as the "scientific establishment." The focus on a vaccine-autism link echoes claims first popularized by a 1998 study in The Lancet by Andrew Wakefield. That study, which asserted a link between the MMR vaccine and autism, was later debunked and refuted by decades of global scientific research.

This current push follows a previous action taken by the president on May 29, 2026. That executive order directed federal health agencies to review and potentially narrow the list of recommended childhood vaccines, indicating a systemic effort to alter the existing immunization framework.

Implications for Public Health

Medical experts warn that an official federal probe into a debunked link could severely undermine public confidence in childhood immunization programs. Such a shift in government stance may lead to lower vaccination rates across the country, increasing the risk of a resurgence of preventable diseases that had previously been controlled or eliminated.

Beyond the immediate health risks, the move represents a significant departure in the U.S. government's relationship with established medical science and its own public health agencies. By elevating a discredited theory to the level of a federal investigation, the administration is fundamentally altering the evidentiary standards used to guide national health policy.

What to Watch

Observers are now waiting to see the final language of the executive order and which specific federal agencies will be tasked with the review. It remains to be seen how the leadership within those agencies will respond to the directive, given the existing body of scientific evidence. The administration has not yet specified the timeline for the probe or the exact parameters of the research it intends to conduct.